CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops advanced drug delivery systems using cyclodextrins to enhance the effectiveness of cancer treatments. By creating new derivatives, the aim is to improve drug solubility, targeting, and overcome drug resistance, ultimately leading to more effective photodynamic therapy.
There is a high demand for the development of new drug delivery strategies to combat major diseases in our society, particularly cancer.
Current treatments are based on high efficacy drugs, however their non-selective uptake by both normal and tumor cells as well as the development of multidrug resistance (MDR), constitute major hurdles.
Resistance is also associated with the use of nucleoside analogues as anticancer drugs in vivo.
Photodynamic therapy (PDT), aims at selectively killing neoplast…
NATIONAL CENTER FOR SCIENTIFIC RESEARCH ""DEMOKRITOS""""
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Ciudad Real
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Iceland, Reykjavik
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Catania
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
